查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1363362

鴉片類藥物市場規模、佔有率和趨勢分析報告：按產品、按用途、按給藥途徑、按配銷通路、按地區和細分趨勢，2023-2030

Opioid Market Size, Share & Trends Analysis Report By Product (IR/ Short Acting Opioids, ER/Long-Acting Opioids), Application (Pain Relief, Anesthesia), Route Of Administration, Distribution Channel, Region, & Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

鴉片類藥物市場成長與趨勢：

Grand View Research, Inc.最新報告顯示，到2030年，全球鴉片類藥物市場規模預計將達到253億美元，預測期內年複合成長率為1.4%。

支持性法規政策幫助製造商推出有潛力促進市場成長的產品。例如，2021年6月，美國FDA核准了Purdue Pharma LP開發的鹽酸納美芬注射。納美芬注射是一種鴉片拮抗，目的是逆轉鴉片類藥物過量攝取。該產品的核准預計將推動成長。

此外，2021年 6月，硫酸嗎啡錠劑和硫酸嗎啡口服液獲得 FDA核准，用於治療幾乎沒有其他治療選擇的兒童和成人患者的嚴重疼痛。因此，新的鴉片類藥物的核准及其推出也有望推動成長。

擴大使用鴉片類藥物來控制手術後疼痛也有望推動市場成長。根據加拿大藥物使用和成癮中心的資料，2020年約有 11.8%的人口使用鴉片類止痛藥來控制症狀。在該地區，曲馬多和可待因經常作為術後鴉片類藥物處方。

由於用於疼痛管理的鴉片類藥物的非成癮替代品的出現，鴉片類藥物市場的成長下降。據美國麻醉醫師協會指出，有幾種非類固醇消炎劑，如阿斯匹靈、乙醯胺酚和對乙醯氨基酚。此外，與這些藥物相關的廣泛可得性和低成本導致預測期內此類產品的需求增加。例如，阿斯匹靈每包 30 片的售價為 10 美元。

此外，2022年 2月，美國FDA 根據 HHS 急性和慢性疼痛管理過量攝取預防策略發起了一項計劃，鼓勵開發非成癮性止痛藥來取代鴉片類藥物。 FDA 鼓勵製藥公司開發非鴉片類止痛藥。這些配合措施可能會限制鴉片類藥物市場的整體成長。

鴉片類藥物市場報告亮點

  • 依產品分類，由於新的緩釋/長效鴉片領域藥物的核准和上市數量增加，緩釋/長效鴉片類藥物細分市場在2022年佔據了最大的市場佔有率。例如，2021年6月，美國FDA接受了丁丙諾啡（Brixadi）用於疼痛管理的新藥認證申請。丁丙諾啡是一種緩釋性、長效的鴉片類藥物。
  • 從用途來看，預計2022年止痛領域將主導鴉片類藥物市場，由於慢性疼痛患者的增加，預計市場將顯著成長。根據加拿大健康資訊研究所和加拿大疼痛工作小組2021年的報告，加拿大有五分之一的成年人患有慢性疼痛。
  • 從給藥途徑來看，注射劑在2022年佔據鴉片類藥物市場的主導地位。這一優點是由於用於治療慢性疼痛的產品的廣泛使用以及需要麻醉的手術數量的增加。
  • 從配銷通路來看，2022年鴉片類藥物市場零售藥局佔據主導地位。該領域的成長是由鴉片類藥物配藥率較高的零售藥局的存在所推動的。
  • 預計亞太地區在預測期內成長最快。老齡化人口更容易罹患慢性疼痛，該地區的成長是由於人口老化的增加。

目錄

第1章 調查方法和範圍

第2章 執行摘要

第3章 鴉片類藥物市場變數、趨勢與範圍

  • 市場體系預測
    • 母市場預測
    • 相關/附隨市場預測
  • 普及和成長預測圖
  • 市場動態
    • 市場促進因素分析
    • 市場抑制因素分析
  • 鴉片類藥物市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章 鴉片類藥物：依產品分類的估算與趨勢分析

  • 鴉片類藥物市場：要點
  • 鴉片類藥物市場：2022年和2030年趨勢和市場佔有率分析
  • IR/短效鴉片類藥物
  • ER/長效型鴉片類藥物

第5章 鴉片類藥物：依用途估算與趨勢分析

  • 鴉片類藥物市場：要點
  • 鴉片類藥物市場：2022年和2030年趨勢和市場佔有率分析
  • 止痛藥
  • 麻醉
  • 止咳藥
  • 抑制腹瀉
  • 戒成癮

第6章 鴉片類藥物：按給藥途徑的估計和趨勢分析

  • 鴉片類藥物市場：要點
  • 鴉片類藥物市場：2022年和2030年趨勢和市場佔有率分析
  • 口服
  • 注射
  • 其他

第7章 鴉片類藥物：按配銷通路的估計和趨勢分析

  • 鴉片類藥物市場：要點
  • 鴉片類藥物市場：2022年和2030年趨勢和市場佔有率分析
  • 醫院藥房
  • 零售藥房
  • 其他

第8章 鴉片類藥物市場：區域估計和趨勢分析

  • 區域展望
  • 依地區分類的鴉片類藥物市場：要點
  • 北美洲
    • 2018-2030年市場估計與預測
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 瑞典
    • 挪威
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東、非洲
    • 沙烏地阿拉伯
    • 南非
    • 阿拉伯聯合大公國
    • 科威特

第9章 競爭形勢

  • 主要市場參與企業的最新趨勢和影響分析
  • 市場參與企業分類
    • Purdue Pharma LP
    • Johnson & Johnson Services, Inc.
    • Hikma Pharmaceuticals PLC
    • Pfizer Inc.
    • AbbVie Inc.
    • Sanofi
    • Sun Pharmaceutical Industries Ltd
    • Grunenthal
    • Merck & Co., Inc.
Product Code: GVR-2-68038-131-3

Opioids Market Growth & Trends:

The global opioid market size is expected to reach USD 25.3 billion by 2030, registering a CAGR of 1.4% during the forecast period, according to a new report by Grand View Research, Inc.. Supportive regulatory policies aid manufacturers to introduce products that may contribute to the market growth. For instance, in June 2021, the U.S. FDA approved nalmefene hydrochloride injection developed by Purdue Pharma L.P.Nalmefene injectable is an opioid antagonist designed to reverse opioid overdose. The expected approval of a product is anticipated to drive the growth.

Moreover, in June 2021, morphine sulfate tablets and morphine sulfate oral solution were approved by FDA for the management of severe pain in pediatric and adult patients for whom other treatment options were less. Thus, approval of new opioid and their launch is also expected to drive the growth.

Growing use of the opioids for the management of post-operative pain, caused due to the surgeries, is expected to drive the market growth. According to the Canadian Centre on Substance Use and Addiction, in 2020, approximately 11.8% of all the population used opioid analgesics for the management of symptoms. Tramadol and codeine are frequently dispensed for the postoperative opioid prescription in surgeries within the region.

Emergence of non-addictive alternative products to opioids for the pain-management leads to decline in the growth of opioid market. According to American Society of Anesthesiologists, there are several non-opioid medicines that are available over the counter steroids and NSAIDs such as aspirin, ibuprofen, and acetaminophen among others. Furthermore, wide availability and low cost associated with these drugs contribute to increase in demand for such products during the forecast period. For instance, aspirin cost USD 10 for a pack of 30 tablets.

In addition, in February 2022, the U.S. FDA has undertaken an initiative to encourage the development of non-addictive analgesics alternatives to opioids under its HHS overdose prevention strategy for the management of acute and chronic pain. The regulatory agency issued recommendation to pharmaceutical companies to develop non-opioid analgesic products. Such initiatives may restrain the overall growth of the opioids market.

Opioids Market Report Highlights:

  • By product, ER/long acting opioids segment held the largest market share in 2022 due to the increasing approval and launch of the novel ER/ long-acting opioids. For instance, in June 2021, the U.S. FDA accepted a review application for a new drug application for buprenorphine (Brixadi) for the pain management. Buprenorphine is an extended release long-acting opioid drug
  • By application, pain relief segment dominated the opioids market in 2022 and is expected to witness significant market growth owing to increasing prevalence of the patients with chronic pain. According to the Canadian Institute for Health Information and Canadian Pain Task Force report of 2021, 1 in every 5 adults in Canada suffers from chronic pain
  • By route of administration, injectable segment dominated the opioids market in 2022. This dominance can be attributed to wide availability of products used for the treatment of chronic pain and increased procedures requiring anesthesia
  • By distribution channel, retail pharmacy dominated the opioids market in 2022. The availability of retail pharmacies with high dispensing rate of opioid driving segment growth
  • Asia pacific is expected to be the fastest growing region during the forecast period. The growth of the region can be attributed to increasing geriatric population which are susceptible to the chronic pain.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product
    • 1.1.2. Application
    • 1.1.3. Route of administration
    • 1.1.4. Distribution channel
    • 1.1.5. Regional scope
    • 1.1.6. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Application outlook
    • 2.2.3. Route of administration outlook
    • 2.2.4. Distribution channel outlook
    • 2.2.5. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Opioids Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Opioids Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Opioids: Product Estimates & Trend Analysis

  • 4.1. Opioids Market: Key Takeaways
  • 4.2. Opioids Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. IR/Short Acting Opioids
    • 4.3.1. IR/ Short Acting Opioids market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. ER/Long Acting Opioids
    • 4.4.1. ER/ Long Acting Opioids market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Opioids: Application Estimates & Trend Analysis

  • 5.1. Opioids Market: Key Takeaways
  • 5.2. Opioids Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Pain Relief
    • 5.3.1. Pain relief market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Anesthesia
    • 5.4.1. Anesthesia market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Cough Suppression
    • 5.5.1. Cough suppression market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.6. Diarrhea Suppression
    • 5.6.1. Diarrhea suppression market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.7. De-addiction
    • 5.7.1. De-addiction market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Opioids: Route of Administration Estimates & Trend Analysis

  • 6.1. Opioids Market: Key Takeaways
  • 6.2. Opioids Market: Movement & Market Share Analysis, 2022 & 2030
  • 6.3. Oral
    • 6.3.1. Oral market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.4. Injectable
    • 6.4.1. Injectable market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.5. Others
    • 6.5.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Opioids: Distribution Channel Estimates & Trend Analysis

  • 7.1. Opioids Market: Key Takeaways
  • 7.2. Opioids Market: Movement & Market Share Analysis, 2022 & 2030
  • 7.3. Hospital Pharmacy
    • 7.3.1. Hospital pharmacy market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.4. Retail Pharmacy
    • 7.4.1. Retail Pharmacy market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.5. Others
    • 7.5.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 8. Opioids Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Outlook
  • 8.2. Opioids Market by Region: Key Takeaways
  • 8.3. North America
    • 8.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.3.2. U.S.
      • 8.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.3.3. Canada
      • 8.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.4. Europe
    • 8.4.1. UK
      • 8.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.4.2. Germany
      • 8.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.4.3. France
      • 8.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.4.4. Italy
      • 8.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.4.5. Spain
      • 8.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.4.6. Sweden
      • 8.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.4.7. Norway
      • 8.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.4.8. Denmark
      • 8.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.5. Asia Pacific
    • 8.5.1. Japan
      • 8.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.5.2. China
      • 8.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.5.3. India
      • 8.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.5.4. Australia
      • 8.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.5.5. Thailand
      • 8.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.5.6. South Korea
      • 8.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.6. Latin America
    • 8.6.1. Brazil
      • 8.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.6.2. Mexico
      • 8.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.6.3. Argentina
      • 8.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.7. MEA
    • 8.7.1. Saudi Arabia
      • 8.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.7.2. South Africa
      • 8.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.7.3. UAE
      • 8.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.7.4. Kuwait
      • 8.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 9.2. Market Participant Categorization
    • 9.2.1. Purdue Pharma L.P.
      • 9.2.1.1. Company overview
      • 9.2.1.2. Financial performance
      • 9.2.1.3. Product benchmarking
      • 9.2.1.4. Strategic initiatives
    • 9.2.2. Johnson & Johnson Services, Inc.
      • 9.2.2.1. Company overview
      • 9.2.2.2. Financial performance
      • 9.2.2.3. Product benchmarking
      • 9.2.2.4. Strategic initiatives
    • 9.2.3. Hikma Pharmaceuticals PLC
      • 9.2.3.1. Company overview
      • 9.2.3.2. Financial performance
      • 9.2.3.3. Product benchmarking
      • 9.2.3.4. Strategic initiatives
    • 9.2.4. Pfizer Inc.
      • 9.2.4.1. Company overview
      • 9.2.4.2. Financial performance
      • 9.2.4.3. Product benchmarking
      • 9.2.4.4. Strategic initiatives
    • 9.2.5. AbbVie Inc.
      • 9.2.5.1. Company overview
      • 9.2.5.2. Financial performance
      • 9.2.5.3. Product benchmarking
      • 9.2.5.4. Strategic initiatives
    • 9.2.6. Sanofi
      • 9.2.6.1. Company overview
      • 9.2.6.2. Financial performance
      • 9.2.6.3. Product benchmarking
      • 9.2.6.4. Strategic initiatives
    • 9.2.7. Sun Pharmaceutical Industries Ltd
      • 9.2.7.1. Company overview
      • 9.2.7.2. Financial performance
      • 9.2.7.3. Product benchmarking
      • 9.2.7.4. Strategic initiatives
    • 9.2.8. Grunenthal
      • 9.2.8.1. Company overview
      • 9.2.8.2. Financial performance
      • 9.2.8.3. Product benchmarking
      • 9.2.8.4. Strategic initiatives
    • 9.2.9. Merck & Co., Inc.
      • 9.2.9.1. Company overview
      • 9.2.9.2. Financial performance
      • 9.2.9.3. Product benchmarking
      • 9.2.9.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 North America opioids market, by product, 2018 - 2030 (USD Million)
  • Table 3 North America opioids market, by application, 2018 - 2030 (USD Million)
  • Table 4 North America opioids market, by route of administration, (USD Million) 2018 - 2030
  • Table 5 North America opioids market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 6 North America opioids market, by region, 2018 - 2030 (USD Million)
  • Table 7 U.S. opioids market, by product, 2018 - 2030 (USD Million)
  • Table 8 U.S. opioids market, by application, 2018 - 2030 (USD Million)
  • Table 9 U.S. opioids market, by route of administration, (USD Million) 2018 - 2030
  • Table 10 U.S. opioids market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 11 Canada opioids market, by product, 2018 - 2030 (USD Million)
  • Table 12 Canada opioids market, by application, 2018 - 2030 (USD Million)
  • Table 13 Canada opioids market, by route of administration, (USD Million) 2018 - 2030
  • Table 14 Canada opioids market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 15 Europe opioids market, by product, 2018 - 2030 (USD Million)
  • Table 16 Europe opioids market, by application, 2018 - 2030 (USD Million)
  • Table 17 Europe opioids market, by route of administration, (USD Million) 2018 - 2030
  • Table 18 Europe opioids market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 19 Europe opioids market, by region, 2018 - 2030 (USD Million)
  • Table 20 Germany opioids market, by product, 2018 - 2030 (USD Million)
  • Table 21 Germany opioids market, by application, 2018 - 2030 (USD Million)
  • Table 22 Germany opioids market, by route of administration, (USD Million) 2018 - 2030
  • Table 23 Germany opioids market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 24 UK opioids market, by product, 2018 - 2030 (USD Million)
  • Table 25 UK opioids market, by application, 2018 - 2030 (USD Million)
  • Table 26 UK opioids market, by route of administration, (USD Million) 2018 - 2030
  • Table 27 UK opioids market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 28 France opioids market, by product, 2018 - 2030 (USD Million)
  • Table 29 France opioids market, by application, 2018 - 2030 (USD Million)
  • Table 30 France opioids market, by route of administration, (USD Million) 2018 - 2030
  • Table 31 France opioids market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 32 Italy opioids market, by product, 2018 - 2030 (USD Million)
  • Table 33 Italy opioids market, by application, 2018 - 2030 (USD Million)
  • Table 34 Italy opioids market, by route of administration, (USD Million) 2018 - 2030
  • Table 35 Italy opioids market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 36 Spain opioids market, by product, 2018 - 2030 (USD Million)
  • Table 37 Spain opioids market, by application, 2018 - 2030 (USD Million)
  • Table 38 Spain opioids market, by route of administration, (USD Million) 2018 - 2030
  • Table 39 Spain opioids market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 40 Denmark opioids market, by product, 2018 - 2030 (USD Million)
  • Table 41 Denmark opioids market, by application, 2018 - 2030 (USD Million)
  • Table 42 Denmark opioids market, by route of administration, (USD Million) 2018 - 2030
  • Table 43 Denmark opioids market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 44 Sweden opioids market, by product, 2018 - 2030 (USD Million)
  • Table 45 Sweden opioids market, by application, 2018 - 2030 (USD Million)
  • Table 46 Sweden opioids market, by route of administration, (USD Million) 2018 - 2030
  • Table 47 Sweden opioids market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 48 Norway opioids market, by product, 2018 - 2030 (USD Million)
  • Table 49 Norway opioids market, by application, 2018 - 2030 (USD Million)
  • Table 50 Norway opioids market, by route of administration, (USD Million) 2018 - 2030
  • Table 51 Norway opioids market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 52 Asia Pacific opioids market, by product, 2018 - 2030 (USD Million)
  • Table 53 Asia Pacific opioids market, by application, 2018 - 2030 (USD Million)
  • Table 54 Asia Pacific opioids market, by route of administration, (USD Million) 2018 - 2030
  • Table 55 Asia Pacific opioids market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 56 Asia Pacific opioids market, by region, 2018 - 2030 (USD Million)
  • Table 57 Japan opioids market, by product, 2018 - 2030 (USD Million)
  • Table 58 Japan opioids market, by application, 2018 - 2030 (USD Million)
  • Table 59 Japan opioids market, by route of administration, (USD Million) 2018 - 2030
  • Table 60 Japan opioids market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 61 China opioids market, by product, 2018 - 2030 (USD Million)
  • Table 62 China opioids market, by application, 2018 - 2030 (USD Million)
  • Table 63 China opioids market, by route of administration, (USD Million) 2018 - 2030
  • Table 64 China opioids market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 65 India opioids market, by product, 2018 - 2030 (USD Million)
  • Table 66 India opioids market, by application, 2018 - 2030 (USD Million)
  • Table 67 India opioids market, by route of administration, (USD Million) 2018 - 2030
  • Table 68 India opioids market, by distribution channel, (USD Million) 2018 - 2030
  • Table 69 Australia opioids market, by product, 2018 - 2030 (USD Million)
  • Table 70 Australia opioids market, by application, 2018 - 2030 (USD Million)
  • Table 71 Australia opioids market, by route of administration, (USD Million) 2018 - 2030
  • Table 72 Australia opioids market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 73 Thailand opioids market, by product, 2018 - 2030 (USD Million)
  • Table 74 Thailand opioids market, by application, 2018 - 2030 (USD Million)
  • Table 75 Thailand opioids market, by route of administration, (USD Million) 2018 - 2030
  • Table 76 Thailand opioids market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 77 South Korea opioids market, by product, 2018 - 2030 (USD Million)
  • Table 78 South Korea opioids market, by application, 2018 - 2030 (USD Million)
  • Table 79 South Korea opioids market, by route of administration, 2018 - 2030 (USD Million)
  • Table 80 South Korea opioids market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 81 Latin America opioids market, by product, 2018 - 2030 (USD Million)
  • Table 82 Latin America opioids market, by application, 2018 - 2030 (USD Million)
  • Table 83 Latin America opioids market, by route of administration, (USD Million) 2018 - 2030
  • Table 84 Latin America opioids market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 85 Latin America opioids market, by region, 2018 - 2030 (USD Million)
  • Table 86 Brazil opioids market, by product, 2018 - 2030 (USD Million)
  • Table 87 Brazil opioids market, by application, 2018 - 2030 (USD Million)
  • Table 88 Brazil opioids market, by route of administration, 2018 - 2030 (USD Million)
  • Table 89 Brazil opioids market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 90 Mexico opioids market, by product, 2018 - 2030 (USD Million)
  • Table 91 Mexico opioids market, by application, 2018 - 2030 (USD Million)
  • Table 92 Mexico opioids market, by route of administration, (USD Million) 2018 - 2030
  • Table 93 Mexico opioids market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 94 Argentina opioids market, by product, 2018 - 2030 (USD Million)
  • Table 95 Argentina opioids market, by application, 2018 - 2030 (USD Million)
  • Table 96 Argentina opioids market, by route of administration, (USD Million) 2018 - 2030
  • Table 97 Argentina opioids market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 98 Middle East and Africa opioids market, by product, 2018 - 2030 (USD Million)
  • Table 99 Middle East and Africa opioids market, by application, 2018 - 2030 (USD Million)
  • Table 100 Middle East and Africa opioids market, by route of administration, (USD Million) 2018 - 2030
  • Table 101 Middle East and Africa opioids market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 102 Middle East and Africa opioids market, by region, 2018 - 2030 (USD Million)
  • Table 103 South Africa opioids market, by product, 2018 - 2030 (USD Million)
  • Table 104 South Africa opioids market, by application, 2018 - 2030 (USD Million)
  • Table 105 South Africa opioids market, by route of administration, (USD Million) 2018 - 2030
  • Table 106 South Africa opioids market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 107 Saudi Arabia opioids market, by product, 2018 - 2030 (USD Million)
  • Table 108 Saudi Arabia opioids market, by application, 2018 - 2030 (USD Million)
  • Table 109 Saudi Arabia opioids market, by route of administration, (USD Million) 2018 - 2030
  • Table 110 Saudi Arabia opioids market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 111 UAE opioids market, by product, 2018 - 2030 (USD Million)
  • Table 112 UAE opioids market, by application, 2018 - 2030 (USD Million)
  • Table 113 UAE opioids market, by route of administration, (USD Million) 2018 - 2030
  • Table 114 UAE opioids market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 115 Kuwait opioids market, by product, 2018 - 2030 (USD Million)
  • Table 116 Kuwait opioids market, by application, 2018 - 2030 (USD Million)
  • Table 117 Kuwait opioids market, by route of administration, 2018 - 2030 (USD Million)
  • Table 118 Kuwait opioids market, by distribution channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Opioids: Market outlook
  • Fig. 9 Opioids: Competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Opioids market driver impact
  • Fig. 15 Opioids market restraint impact
  • Fig. 16 Opioids market strategic initiatives analysis
  • Fig. 17 Opioids market: Product movement analysis
  • Fig. 18 Opioids market: Product outlook and key takeaways
  • Fig. 19 IR/Short acting opioids market estimates and forecasts, 2018 - 2030
  • Fig. 20 ER/Long acting opioids market estimates and forecasts, 2018 - 2030
  • Fig. 21 Opioids market: Application movement analysis
  • Fig. 22 Opioids market: Application outlook and key takeaways
  • Fig. 23 Pain relief market estimates and forecasts, 2018 - 2030
  • Fig. 24 Anesthesia market estimates and forecasts, 2018 - 2030
  • Fig. 25 Cough suppression market estimates and forecasts, 2018 - 2030
  • Fig. 26 Diarrhea suppression market estimates and forecasts, 2018 - 2030
  • Fig. 27 De-addiction market estimates and forecasts, 2018 - 2030
  • Fig. 28 Opioids market: Route of administration movement analysis
  • Fig. 29 Opioids market: Route of administration outlook and key takeaways
  • Fig. 30 Oral market estimates and forecasts, 2018 - 2030
  • Fig. 31 Injectable market estimates and forecasts, 2018 - 2030
  • Fig. 32 Others market estimates and forecasts, 2018 - 2030
  • Fig. 33 Opioids market: Distribution channel movement analysis
  • Fig. 34 Opioids market: Distribution channel outlook and key takeaways
  • Fig. 35 Hospital pharmacy market estimates and forecasts, 2018 - 2030
  • Fig. 36 Retail pharmacy market estimates and forecasts, 2018 - 2030
  • Fig. 37 Others market estimates and forecasts, 2018 - 2030
  • Fig. 38 Global opioids market: Regional movement analysis
  • Fig. 39 Global opioids market: Regional outlook and key takeaways
  • Fig. 40 North America market estimates and forecasts, 2018 - 2030
  • Fig. 41 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 42 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 43 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 44 UK market estimates and forecasts, 2018 - 2030
  • Fig. 45 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 46 France market estimates and forecasts, 2018 - 2030
  • Fig. 47 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 48 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 49 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 50 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 51 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 52 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 53 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 54 China market estimates and forecasts, 2018 - 2030
  • Fig. 55 India market estimates and forecasts, 2018 - 2030
  • Fig. 56 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 57 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 58 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 59 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 60 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 61 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 62 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 63 Middle East and Africa. market estimates and forecasts, 2018 - 2030
  • Fig. 64 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 65 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 66 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 67 Kuwait market estimates and forecasts, 2018 - 2030